{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:43:02Z","timestamp":1790030582643,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ejca.2015.04.027","type":"journal-article","created":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T12:32:05Z","timestamp":1433161925000},"page":"1570-1579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: A Bayesian network meta-analysis"],"prefix":"10.1016","volume":"51","clinical-trial-number":[{"clinical-trial-number":"nct00201396","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00677118","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00705627","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00997906","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01245959","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Marie","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kumachev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian L.","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin K.W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejca.2015.04.027_b0005","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1055-9965.EPI-06-0353","article-title":"The enigmatic epidemiology of nasopharyngeal carcinoma","volume":"15","author":"Chang","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.ejca.2015.04.027_b0020","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ijrobp.2004.07.702","article-title":"Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience","volume":"61","author":"Lee","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ejca.2015.04.027_b0025","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.ijrobp.2008.07.062","article-title":"Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging","volume":"73","author":"Mao","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ejca.2015.04.027_b0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijrobp.2005.06.037","article-title":"Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients","volume":"64","author":"Baujat","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl. 7","key":"10.1016\/j.ejca.2015.04.027_b0035","doi-asserted-by":"crossref","first-page":"vii83","DOI":"10.1093\/annonc\/mds266","article-title":"Nasopharyngeal cancer: EHNS\u2013ESMO\u2013ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Chan","year":"2012","journal-title":"Ann Oncol"},{"issue":"22","key":"10.1016\/j.ejca.2015.04.027_b0040","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1200\/JCO.2004.10.074","article-title":"The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature","volume":"22","author":"Langendijk","year":"2004","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2015.04.027_b0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1470-2045(11)70320-5","article-title":"Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial","volume":"13","author":"Chen","year":"2012","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2015.04.027_b0050","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S1470-2045(13)70388-7","article-title":"Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis","volume":"14","author":"Liao","year":"2013","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2015.04.027_b0055","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S1470-2045(07)70281-4","article-title":"Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis","volume":"8","author":"Golfinopoulos","year":"2007","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2015.04.027_b0060","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jnci\/djs142","article-title":"Network meta-analysis of margin threshold for women with ductal carcinoma in situ","volume":"104","author":"Wang","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2015.04.027_b0065","unstructured":"Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011 < www.cochrane-handbook.org>."},{"issue":"2","key":"10.1016\/j.ejca.2015.04.027_b0070","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ."},{"issue":"24","key":"10.1016\/j.ejca.2015.04.027_b0075","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2015.04.027_b0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"10.1016\/j.ejca.2015.04.027_b0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1008929526011","article-title":"WinBUGS \u2013 a Bayesian modelling framework: concepts, structure, and extensibility","volume":"10","author":"Lunn","year":"2000","journal-title":"Stat Comput"},{"issue":"7223","key":"10.1016\/j.ejca.2015.04.027_b0090","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1136\/bmj.319.7223.1492","article-title":"Calculating the number needed to treat for trials where the outcome is time to an event","volume":"319","author":"Altman","year":"1999","journal-title":"BMJ"},{"issue":"7168","key":"10.1016\/j.ejca.2015.04.027_b0095","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/bmj.317.7168.1309","article-title":"Confidence intervals for the number needed to treat","volume":"317","author":"Altman","year":"1998","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ejca.2015.04.027_b0100","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099","volume":"16","author":"Al-Sarraf","year":"1998","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2015.04.027_b0105","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/jnci\/dji084","article-title":"Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma","volume":"97","author":"Chan","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.ejca.2015.04.027_b0110","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.2003.06.158","article-title":"Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival","volume":"21","author":"Lin","year":"2003","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2015.04.027_b0115","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/annonc\/mdt163","article-title":"Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma","volume":"24","author":"Wu","year":"2013","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2015.04.027_b0120","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/cncr.28049","volume":"119","author":"Chen","year":"2013","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.ejca.2015.04.027_b0125","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/jnci\/djq258","article-title":"Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma","volume":"102","author":"Lee","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.ejca.2015.04.027_b0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2010.09.023","article-title":"A randomized trial on addition of concurrent-adjuvant chemotherapy and\/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma","volume":"98","author":"Lee","year":"2011","journal-title":"Radiother Oncol"},{"issue":"27","key":"10.1016\/j.ejca.2015.04.027_b0135","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1200\/JCO.2005.16.790","article-title":"Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer\/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety","volume":"23","author":"Wee","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2015.04.027_b0140","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/annonc\/mdr116","volume":"23","author":"Fountzilas","year":"2012","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2015.04.027_b0145","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1200\/JCO.2008.18.1545","article-title":"Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma","volume":"27","author":"Hui","year":"2009","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2015.04.027_b0150","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2270::AID-CNCR6>3.3.CO;2-K","volume":"83","author":"Chua","year":"1998","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2015.04.027_b0155","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0360-3016(96)80007-1","volume":"35","author":"International Nasopharynx Cancer Study Group","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.ejca.2015.04.027_b0160","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/cncr.10473","article-title":"A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma","volume":"94","author":"Hareyama","year":"2002","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2015.04.027_b0165","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1200\/JCO.2001.19.5.1350","article-title":"Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma","volume":"19","author":"Ma","year":"2001","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2015.04.027_b0170","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0360-3016(01)02781-X","article-title":"A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients","volume":"52","author":"Chi","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.ejca.2015.04.027_b0175","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1200\/JCO.1988.6.9.1401","article-title":"Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study","volume":"6","author":"Rossi","year":"1988","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2015.04.027_b0180","first-page":"1","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy vs concurrent chemoradiotherapy followed by chemotherapy in the treatment of patients with advanced nasopharyngeal carcinoma","volume":"49","author":"Ruste","year":"2011","journal-title":"Phillippine J Int Med"},{"issue":"3","key":"10.1016\/j.ejca.2015.04.027_b0185","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0360-3016(95)00218-N","article-title":"A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma","volume":"33","author":"Chan","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.ejca.2015.04.027_b0190","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.oraloncology.2012.04.006","article-title":"A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma","volume":"48","author":"Huang","year":"2012","journal-title":"Oral Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2015.04.027_b0195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.oraloncology.2013.11.002","article-title":"A phase III randomized study comparing neoadjuvant chemotherapy with concurrent chemotherapy combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma: updated long-term survival outcomes","volume":"50","author":"Xu","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ejca.2015.04.027_b0200","doi-asserted-by":"crossref","unstructured":"Tan T, Lim W-T, Fong K-W, et al. Randomized phase III trial of concurrent chemoradiation with or without neoadjuvant gemcitabine, carboplatin, and paclitaxel in locally advanced nasopharyngeal cancer. J Clin Oncol. 2014;32:5s(Suppl.; abstr 6003). <http:\/\/meetinglibrary.asco.org\/content\/128695-144>.","DOI":"10.1200\/jco.2014.32.15_suppl.6003"},{"issue":"1","key":"10.1016\/j.ejca.2015.04.027_b0205","first-page":"54","article-title":"Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: results of 3-year randomized study","volume":"15","author":"Zhang","year":"1996","journal-title":"Chin J Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2015.04.027_b0210","first-page":"563","article-title":"Chemotherapy adjunctive to definitive radiotherapy in locally advanced nasopharyngeal carcinoma (NPC): prospective randomized study","volume":"13","author":"Ying","year":"2003","journal-title":"Chin Oncol"},{"issue":"13","key":"10.1016\/j.ejca.2015.04.027_b0215","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1200\/JCO.2004.05.173","article-title":"Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study","volume":"22","author":"Kwong","year":"2004","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2015.04.027_b0220","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/annonc\/mdu507","article-title":"A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma","volume":"26","author":"Chen","year":"2015","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2015.04.027_b0225","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/annonc\/mdt146","article-title":"Significant efficacies of neoadjuvant and adjuvant chemotherapy for nasopharyngeal carcinoma by meta-analysis of published literature-based randomized, controlled trials","volume":"24","author":"OuYang","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2015.04.027_b0230","doi-asserted-by":"crossref","unstructured":"Blanchard P, Lee AWM, Leclercq J, et al. Meta-analysis of chemotherapy in nasopharyngeal carcinoma (MAC-NPC): An update on 4,798 patients. J Clin Oncol. 2014;32:5s(suppl.; abstr 6022). <http:\/\/meetinglibrary.asco.org\/content\/132329-144>.","DOI":"10.1200\/jco.2014.32.15_suppl.6022"},{"issue":"2","key":"10.1016\/j.ejca.2015.04.027_b0235","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ijrobp.2004.05.047","article-title":"Prognostic significance of parapharyngeal space venous plexus and marrow involvement: potential landmarks of dissemination for stage I\u2013III nasopharyngeal carcinoma","volume":"61","author":"Cheng","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915003895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915003895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T22:46:26Z","timestamp":1599086786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804915003895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0959804915003895"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2015.04.027","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: A Bayesian network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2015.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}